MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

How does the PPP2R2B mutation alter neuronal cytoskeletal structure in SCA12

A. Ganguly, B. Reddy, J. Rungta, S. Choudhury, R. Pal, H. Kumar, S. Chattarji (Kolkata, India)

Meeting: 2024 International Congress

Abstract Number: 1278

Keywords: Ataxia: Etiology and Pathogenesis, Cognitive dysfunction

Category: Ataxia

Objective: To study the effect of the PPP2R2B mutation on human induced pluripotent stem cell (iPSC) derived neurons in SCA12 patients.

Background: SCA12 is an autosomal dominant ataxia syndrome attributed to an increased number of CAG repeats due to a mutated PPP2R2B gene (encodes for PP2A). PP2A is known to regulate cellular processes by dephosphorylation, thereby controlling signal transduction pathways involved in cell growth, division, and survival.  SCA12 is characterized by late-onset ataxia and action tremor along with other cerebellar motor symptoms. Cognitive impairment is also a part of the disease spectrum, though masked due to profound motor manifestations. Radiological and post-mortem studies have revealed atrophy of both cerebellum and cortex, including the association areas. However, how this mutation impacts specific cell types, leading to such cognitive dysfunctions, is unclear. Since, brain biopsy is not feasible in such patients, iPSCs serve as an invaluable system for studying such disorders and potential therapeutic interventions.

Method: A genetically confirmed SCA12 patient and healthy sibling with similar demographics were identified at the movement disorder clinic, I-NK, Kolkata. After ethical approval and informed consent, iPSCs were derived, and further subjected to ectodermal lineage specification, followed by differentiation and maturation into neurons. To carry out detailed morphological analysis of the SCA12 neurons, cells were immunophenotyped for cytoskeletal proteins – MAP2ab in neurons and GFAP in astrocytes.

Results: Further, images captured were used for analysis of cell number, soma size and neuron-glia (N-G) ratio. Data suggests a significantly smaller soma size of the SCA12 neurons. Based on these results we further propose to study PP2A’s role in cytoskeletal modifications. The number of SCA12 neurons seemed to be higher, but N-G ratio was not different.

Conclusion: Other neurological disorders like Schizophrenia have reported similar decreases in cell sizes. The extent of a neuron’s axonal and dendritic arbor is correlated to size. A decrease in the same may reflect reduction in the afferent -efferent connectivity of neurons. This can subsequently be responsible for the cognitive deficits observed. The decreased soma size and the apparent differences in the number of neurons are currently being investigated in more detail in our laboratory.

To cite this abstract in AMA style:

A. Ganguly, B. Reddy, J. Rungta, S. Choudhury, R. Pal, H. Kumar, S. Chattarji. How does the PPP2R2B mutation alter neuronal cytoskeletal structure in SCA12 [abstract]. Mov Disord. 2024; 39 (suppl 1). https://www.mdsabstracts.org/abstract/how-does-the-ppp2r2b-mutation-alter-neuronal-cytoskeletal-structure-in-sca12/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2024 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/how-does-the-ppp2r2b-mutation-alter-neuronal-cytoskeletal-structure-in-sca12/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley